NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of BioHarvest Sciences Inc. (OTCQB: CNVCF, CSE: BHSC). The in-depth 35-page initiation report includes detailed information on the BioHarvest Sciences’ business model, services, industry, valuation, management, and risks. The full research report is available here. Highlights from the report include: Pioneering the Wellne
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV) ("BioHarvest" or the "Company") has closed the first tranche of its private placement announced on June 21, 2024. The Company issued 603,904 share units at USD $7.17 per unit raising a total of USD $4,329,982.62 (approx. CAD $5,926,000). Each unit includes one common share, one-quarter of a USD $7.68 warrant expiring in 6 months, ...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024.CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will hos